Drug Shortage Crisis Worsens
200-Plus Products Are In Short Supply In Most EU Countries
As efforts continue to find ways of mitigating medicine shortages, a European survey has found not only that the situation is worsening, but that efforts to improve things are hindered by the patchwork of different rules on substitution and importation across the EU.
You may also be interested in...
Belgium is to impose new reporting obligations on pharmaceutical companies that become aware of drug supply interruptions, in a move that is seen by suppliers as less draconian than measures taken in other European countries.
A single point of contact network that is expected to help EU countries share information on medicines shortages has completed its first phase and will be spread more widely this year.
A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.